Global Human Liver Model Market Report 2022: Emerging 3D and 2D Trends in Modeling Human Liver Disease in Vitro Fuel Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Sep 30, 2022--

The "Human Liver Model Market Research Report by Product (2D Models, 3D Bio Printing, and Liver Organoids), Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Human Liver Model Market size was estimated at USD 1,812.28 million in 2021, USD 2,025.82 million in 2022, and is projected to grow at a CAGR 11.95% to reach USD 3,569.37 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Human Liver Model to forecast the revenues and analyze the trends in each of the following sub-markets:

• Based on Product, the market was studied across 2D Models, 3D Bio Printing, and Liver Organoids.
• Based on Application, the market was studied across Drug Discovery and Education.
• Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Human Liver Model Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Market Dynamics

Drivers

• Rising Prevalence Rate of Non-Alcoholic Fatty Liver Disease
• Emerging 3D and 2D Trends in Modeling Human Liver Disease in Vitro
• Rising Initiatives and Awareness About Liver Organoids

Restraints

• Lack of Skilled and Trained Professionals

Opportunities

• Growing Focus on Drug Discovery Activities
• Potential Growth of Healthcare in the Asia-Pacific and Latin America

Challenges

• Generation of Complex Human Organoid Models

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

6. Human Liver Model Market, by Product

7. Human Liver Model Market, by Application

8. Americas Human Liver Model Market

9. Asia-Pacific Human Liver Model Market

10. Europe, Middle East & Africa Human Liver Model Market

11. Competitive Landscape

12. Company Usability Profiles

13. Appendix

Companies Mentioned

• BioIVT LLC
• Biopredic International
• CELLINK GLOBAL
• CN Bio Innovations
• Cyfuse Biomedical K.K.
• Emulate Inc.
• HREL Corporation
• InSphero AG
• MIMETAS B.V.
• NeurOmics, Inc.
• Organovo Holdings Inc
• STEMCELL Technologies Inc.
• Thermo Fisher Scientific Inc.
• ZenBio, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/5hf1du

View source version on businesswire.com:https://www.businesswire.com/news/home/20220930005357/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2022.